AU2018900325A0 - Parenteral Formulations and Uses Thereof - Google Patents

Parenteral Formulations and Uses Thereof

Info

Publication number
AU2018900325A0
AU2018900325A0 AU2018900325A AU2018900325A AU2018900325A0 AU 2018900325 A0 AU2018900325 A0 AU 2018900325A0 AU 2018900325 A AU2018900325 A AU 2018900325A AU 2018900325 A AU2018900325 A AU 2018900325A AU 2018900325 A0 AU2018900325 A0 AU 2018900325A0
Authority
AU
Australia
Prior art keywords
parenteral formulations
parenteral
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900325A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eustralis Pharmaceuticals Ltd
Original Assignee
Eustralis Pharmaceuticals Ltd
Filing date
Publication date
Application filed by Eustralis Pharmaceuticals Ltd filed Critical Eustralis Pharmaceuticals Ltd
Publication of AU2018900325A0 publication Critical patent/AU2018900325A0/en
Priority to PCT/AU2019/050075 priority Critical patent/WO2019148246A1/en
Priority to MX2020008138A priority patent/MX2020008138A/en
Priority to EP19747397.8A priority patent/EP3746077A4/en
Priority to US16/966,286 priority patent/US11801244B2/en
Priority to AU2019215801A priority patent/AU2019215801A1/en
Priority to CA3089662A priority patent/CA3089662A1/en
Priority to CN201980013727.4A priority patent/CN111741755B/en
Priority to JP2020541497A priority patent/JP7400180B2/en
Priority to ZA2020/05144A priority patent/ZA202005144B/en
Priority to US18/372,979 priority patent/US20240091221A1/en
Abandoned legal-status Critical Current

Links

AU2018900325A 2018-02-02 2018-02-02 Parenteral Formulations and Uses Thereof Abandoned AU2018900325A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2020541497A JP7400180B2 (en) 2018-02-02 2019-02-01 Parenteral preparations and their use
AU2019215801A AU2019215801A1 (en) 2018-02-02 2019-02-01 Parenteral formulations and uses thereof
MX2020008138A MX2020008138A (en) 2018-02-02 2019-02-01 Parenteral formulations and uses thereof.
EP19747397.8A EP3746077A4 (en) 2018-02-02 2019-02-01 Parenteral formulations and uses thereof
US16/966,286 US11801244B2 (en) 2018-02-02 2019-02-01 Parenteral formulations and uses thereof
PCT/AU2019/050075 WO2019148246A1 (en) 2018-02-02 2019-02-01 Parenteral formulations and uses thereof
CA3089662A CA3089662A1 (en) 2018-02-02 2019-02-01 Parenteral formulations and uses thereof
CN201980013727.4A CN111741755B (en) 2018-02-02 2019-02-01 Parenteral formulations and uses thereof
ZA2020/05144A ZA202005144B (en) 2018-02-02 2020-08-19 Parenteral formulations and uses thereof
US18/372,979 US20240091221A1 (en) 2018-02-02 2023-09-26 Parenteral formulations and uses thereof

Publications (1)

Publication Number Publication Date
AU2018900325A0 true AU2018900325A0 (en) 2018-02-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP3746124A4 (en) Compounds and uses thereof
EP3823673A4 (en) Anti-cd112r compositions and methods
EP3752612A4 (en) Modified compounds and uses thereof
EP4076448A4 (en) Fluoroalkyl-oxadiazoles and uses thereof
EP3841096A4 (en) Pyridinylmethylenepiperidine derivatives and uses thereof
EP3838900A4 (en) 3-aryloxy-3-aryl-propylamine compound and uses thereof
EP3790861A4 (en) Senolytic compositions and uses thereof
EP3843736A4 (en) Isoquinoline-steroid conjugates and uses thereof
EP4037670A4 (en) 5-fluoronicotinamide derivatives and uses thereof
EP3808357A4 (en) Composition and uses thereof
EP3723811A4 (en) Hsp90-targeting conjugates and formulations thereof
EP3853216A4 (en) Substituted-pyridinyl compounds and uses thereof
EP3768269A4 (en) Compounds and uses thereof
EP3844500A4 (en) Rp182 compositions and methods
EP3836971A4 (en) Conjugates and methods of using the same
EP3762364A4 (en) Pyrrolidineamide derivatives and uses thereof
EP3845532A4 (en) Quinolino-pyrrolidin-2-one derivative and application thereof
EP3773670A4 (en) Hsp90-targeting conjugates and formulations thereof
EP3691629A4 (en) Nutrient-spore formulations and uses thereof
ZA202005144B (en) Parenteral formulations and uses thereof
EP3897687A4 (en) Antiviral compositions and methods
EP3856755A4 (en) Terpinoid derivatives and uses thereof
EP3716766A4 (en) Benzoxaborole compounds and formulations thereof
EP3729351A4 (en) Fast and partition-resilient blockchains
EP3635324A4 (en) Inverse-freezing compositions and use thereof